Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
---|---|---|---|---|---|---|---|---|---|---|---|
JTH2100044 | Cabotegravir suspension for injection | cabotegravir | Injection | Chemical Drugs | Disposable Import Drug Application | 2021-02-25 | Glaxo Operations UK Limited (trading as Glaxo Wellcome Operations) | Glaxo Operations UK Ltd;GlaxoSmithKline (China) Investment Co Ltd;Viiv Healthcare BV | Certificate Issued | 2021-03-22 | view |
JTH2100045 | Cabotegravir suspension for injection | cabotegravir | Injection | Chemical Drugs | Disposable Import Drug Application | 2021-02-25 | Glaxo Operations UK Limited (trading as Glaxo Wellcome Operations) | Glaxo Operations UK Ltd;GlaxoSmithKline (China) Investment Co Ltd;Viiv Healthcare BV | Certificate Issued | 2021-03-18 | view |